Nuchal translucency and lymphatic system maldevelopment

Journal of Perinatal Medicine

Volumn 37, Issue 6, 2009, Pages 673-676

  Bellini, Carlo ^a   Rutigliani, Mariangela ^b   Boccardo, Francesco M ^b   Bonioli, Eugenio ^a   Campisi, Corradino ^b   Grillo, Federica ^b   Bellini, Tommaso ^a   Valenzano, Mario ^a   Fulcheri, Ezio ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Cystic hygroma; Edema with nuchal cystic lymphangiectasia; Nuchal translucency (NT)

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; PODOPLANIN; SMOOTH MUSCLE ACTIN;

ARTICLE; CLINICAL ARTICLE; CYSTIC LYMPHANGIOMA; GESTATIONAL AGE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHANGIECTASIS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ABORTED FETUS; ACTINS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; ANTIGENS, CD34; COHORT STUDIES; DOWN SYNDROME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIECTASIS; LYMPHANGIOGENESIS; LYMPHANGIOMA, CYSTIC; LYMPHATIC SYSTEM; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 74949127403     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2009.107     Document Type: Article

References (19)

1. Bekker MN, Haak MC, Rekoert-Hollander M, Twisk J, Van Vugt JM. Increased nuchal translucency and distended jugular lymphatic sacs on first-trimester ultrasound. Ultrasound Obstet Gynecol. 2005;25:239-45.
2. Bekker MN, van den Akker NM, Bartelings MM, Arkesteijn JB, Fischer SG, Polman JA, et al. Nuchal edema and venous-lymphatic phenotype disturbance in human fetuses and mouse embryos with aneuploidy. J Soc Gynecol Investig. 2006;13:209-16.
3. Bekker MN, van den Akker NMS, de Mooij YM, Bartelings MM, van Vugt JMG, Gittenberger-de Groot AC. Jugular lymphatic maldevelopment in Turner Syndrome and Trisomy 21: different anomalies leading to nuchal edema. Reproductive Sciences. 2008;15:295-304.
4. Carvalho JS. The fetal heart or the lymphatic system or...? The quest for the etiology of increased nuchal translucency. Ultrasound Obstet Gynecol. 2005;25:215-20.
5. Chitayat D, Kalousek DK, Bamforth JS. Lymphatic abnormalities in fetuses with posterior cervical cystic hygroma. Am J Med Genet. 1989;33:352-6.
6. Dabbs DJ. Diagnostic immunohistochemistry. 2nd ed. Churchill Livingstone: Philadelphia; 2006.
7. Gittenberger-De Groot AC, Van Den Akker NM, Bartelings MM, Webb S, Van Vugt JM, Haak MC. Abnormal lymphatic development in trisomy 16 mouse embryos precedes nuchal edema. Dev Dyn. 2004;230:378-84.
8. Haak MC, Bartelings MM, Jackson DG, Webb S, van Vugt JM, Gittenberger-de Groot AC. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod. 2002;17:1086-92.
9. Haak MC, Bartelings MM, Gittenberger-De Groot AC, Van Vugt JM. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology. Ultrasound Obstet Gynecol. 2002;20:14-21.
10. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest. 2002;82:1255-7.
11. Knisely AS. The pathologist and the hydropic placenta, fetus, or infant. Semin Perinatol. 1995;19:525-31.
12. L'Herminé-Coulomb A. Increased nuchal translucency pathophysiology. J Gynecol Obstet Biol Reprod (Paris). 2005;34(1 Suppl):S89-S96.
13. Molina FS, Avgidou K, Kagan KO, Poggi S, Nicolaides KH. Cystic hygromas, nuchal edema, and nuchal translucency at 11-14 weeks of gestation. Obstet Gynecol. 2006;107: 678-83.
14. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 2005;353:2001-11.
15. Pajkrt E, de Graaf IM, Mol BW, van Lith JM, Bleker OP, Bilardo CM. Weekly nuchal translucency measurements in normal fetuses. Obstet Gynecol. 1998;91:208-11.
16. Sauter B, Foedinger D, Sterniczki B, Wolff K, Rappersberger K. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34 and type IV collagen with lymphatic endothelial cells vs. blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem. 1998:46; 165-76.
17. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005;166:913-21.
18. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998;352: 343-6.
19. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol. 2001;18:9-17.